CAM
MTEM

Cormorant Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Cormorant Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,455
Closed -$354K – 67
2017
Q2 		$354K Hold
5,455
– – 0.06% 67
2017
Q1 		$513K Sell
5,455
-680
-11% -$63.6K 0.07% 69
2016
Q4 		$446K Hold
6,135
– – 0.06% 71
2016
Q3 		$686K Hold
6,135
– – 0.08% 73
2016
Q2 		$643K Buy
6,135
+74
+1% +$5.3K 0.09% 73
2016
Q1 		$460K Hold
6,061
– – 0.07% 77
2015
Q4 		$480K Buy
+6,061
New +$2.99M 0.06% 77

Other funds holding MTEM

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return